he company focuses Its research, development. and commercial efforts on the oncology space, in particular leukemia and lung cancer. V. Fill ° Pet (Wiliam Stair December 23, 2013 Stock Rating: Outperform Company Profile: Aggressive Growth Price Target 512.00 Symbol: ARIA (NASDAQ) Price: 56.43 (52-Wk